Article
Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study.
European journal of clinical nutrition - 1 Jan 2009
Jaakkola U, Kallio J, Heine R J, Nijpels G, T' Hart L M, Maassen J A, Bouter L M, Stehouwer C D A, Dekker J M
Abstract excerpt
The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases. The current study evaluated the impact of obesity on the disease risk linked to the Leu7Pro polymorphism of preproNPY in 393 elderly subjects. In 6 years follow-up, the polymorphism alone did not change the risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
